NCT00578929View on ClinicalTrials.gov

Safety and Efficacy of Olopatadine HCl Nasal Spray in 6-11 Year Old Patients

PHASE3CompletedINTERVENTIONAL

Enrollment

2,388

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

November 30, 2008

Conditions

Seasonal Allergic Rhinitis

Interventions

DRUG

Olopatadine Hydrochloride Nasal Spray 0.6%

Olopatadine HCl 1 or 2 sprays per nostril twice daily

DRUG

Vehicle

Vehicle 1 or 2 sprays per nostril twice daily

Trial Locations (1)

60043

Kenilworth/IL, Kenilworth

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Alcon Research

INDUSTRY